June 11, 2026Solaris has announced the launch of brivaracetam tablets, a generic version of UCB's branded epilepsy medication Briviact. The tablets are…
March 20, 2023Solaris Pharma Corporation is pleased to announce the product approval of Tazarotene Gel, 0.05% and 0.1%.
August 13, 2021Solaris Pharma Corporation located Bridgewater, New Jersey announces the final approval from U.S Food and Drug Administration for its Abbreviated…- April 2, 2021Solaris Pharma Corporation located Bridgewater, New Jersey announces the final approval from U.S Food and Drug Administration for its Abbreviated…
- April 2, 2021Solaris Pharma Corporation located Bridgewater, New Jersey announces the final approval from U.S Food and Drug Administration for its Abbreviated…
- April 2, 2021Solaris Pharma Receives FDA Approval for Fluocinolone Acetonide Topical Oil, 0.01% (Body Oil)Solaris Pharma Corporation located Bridgewater, New Jersey announces…
- July 29, 2020Solaris Pharma Corporation located Bridgewater, New Jersey announces the final approval from U.S Food and Drug Administration for its Abbreviated…
- April 7, 2020Solaris Pharma Corporation located Bridgewater, New Jersey announces the final approval from U.S Food and Drug Administration on for its…
- January 11, 2019Solaris Pharma Corporation located in Bridgewater, New Jersey announces final approval from U.S Food and Drug Administration for its Abbreviated…
